Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed

Irving Waxman

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-1442-056X; OpenAlex author ID A5088448743. Sources: ClinicalTrials.gov.

Their work

Papers
7 (first author 2, last author 0)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
1
Collaborators
38
Papers, trials and grants by year

2010: 1 trial · 2011: none · 2012: 1 paper · 2013: 1 paper · 2014: 1 paper · 2015: 1 paper · 2016: 2 papers · 2017: none · 2018: none · 2019: 1 paper

Papers 7

  1. Changes in tumor vascularity depicted by contrast-enhanced EUS as a predictor of prognosis and treatment efficacy in patients with unresectable pancreatic canc… Co-author DOI 10.4103/eus.eus_16_19↗
  2. Portal-vein blood samples as a new diagnostic entity for pancreatic cancer. First author DOI 10.1080/17474124.2016.1176911↗
  3. State-of-the-art endoscopic procedures for pancreatic cancer. First author DOI 10.2217/fon-2016-0123↗
  4. In vivo risk analysis of pancreatic cancer through optical characterization of duodenal mucosa. Co-author DOI 10.1097/mpa.0000000000000340↗
  5. Enteric duplication cyst of the pancreas associated with chronic pancreatitis and pancreatic cancer. Co-author DOI 10.1007/s11605-013-2434-8↗
  6. Immunohistochemical analysis of E-cadherin and zeste homolog 2 expression in endoscopic ultrasound-guided fine-needle aspiration of pancreatic adenocarcinoma. Co-author DOI 10.1002/cncy.21310↗
  7. EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer… Co-author DOI 10.1016/j.gie.2011.10.007↗

Trials 1

  1. In Vivo nCLE Study in the Pancreas With Endosonography of Cystic Tumors Principal investigator NCT01236300↗

Closest collaborators

The 25 strongest of 38 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Emmanuel S. Coronel · 2 shared papers, 2016–2019 · strength 0.19
  2. Christopher G. Chapman · 1 shared paper, 2016 · strength 0.12
  3. JulioIglesias Garcia · 1 shared paper, 2019 · strength 0.07
  4. Michael Hocke · 1 shared paper, 2019 · strength 0.07
  5. Mariana Jinga · 1 shared paper, 2019 · strength 0.07
  6. ChristophF Dietrich · 1 shared paper, 2019 · strength 0.07
  7. Alina Liliana Constantin · 1 shared paper, 2019 · strength 0.07
  8. Irina Mihaela Cazacu · 1 shared paper, 2019 · strength 0.07
  9. Peter Vilmann · 1 shared paper, 2019 · strength 0.07
  10. Maria Chiara Petrone · 1 shared paper, 2019 · strength 0.07
  11. Paul Yeaton · 1 shared paper, 2019 · strength 0.07
  12. Andrada Seicean · 1 shared paper, 2019 · strength 0.07
  13. Kofi W. Oppong · 1 shared paper, 2019 · strength 0.07
  14. Dong Wan Seo · 1 shared paper, 2019 · strength 0.07
  15. Dan Gabriel Duda · 1 shared paper, 2019 · strength 0.07
  16. Paolo Giorgio Arcidiacono · 1 shared paper, 2019 · strength 0.07
  17. Stephen P. Pereira · 1 shared paper, 2019 · strength 0.07
  18. Manoop S. Bhutani · 1 shared paper, 2019 · strength 0.07
  19. Adrian Săftoiu · 1 shared paper, 2019 · strength 0.07
  20. Takao Itoi · 1 shared paper, 2019 · strength 0.07
  21. Alexander S. Chiu · 1 shared paper, 2014 · strength 0.06
  22. Jeffrey B. Matthews · 1 shared paper, 2014 · strength 0.06
  23. Jeremy D. Rogers · 1 shared paper, 2015 · strength 0.04
  24. Adam Eshein · 1 shared paper, 2015 · strength 0.04
  25. Vadim Backman · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.